Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering.RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000 shares…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
